Sexual function in first-time contraceptive ring and contraceptive patch users

Fertility and Sterility

Volumn 93, Issue 1, 2010, Pages 21-28

  Gracia, Clarisa R ^a   Sammel, Mary D ^a   Charlesworth, Sarah ^a   Lin, Hui ^a   Barnhart, Kurt T ^a   Creinin, Mitchell D ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

arousal; contraception; desire; FSFI; NuvaRing; OrthoEvra; sexuality

Indexed keywords

CONTRACEPTIVE AGENT; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; CONTRACEPTIVE PATCH; CONTRACEPTIVE VAGINAL RING; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FEMALE SEXUAL DYSFUNCTION; HORMONAL CONTRACEPTION; HUMAN; LIBIDO; LUBRICATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OPEN STUDY; ORGASM; PAIN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEXUAL AROUSAL; SEXUAL FUNCTION; SEXUAL SATISFACTION; SEXUALITY; TRANSDERMAL PATCH; VAGINA CONTRACEPTION; VAGINA RING;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, INTRAVAGINAL; ADULT; CONTRACEPTION; CONTRACEPTIVE DEVICES, FEMALE; CONTRACEPTIVES, ORAL, COMBINED; DESOGESTREL; DRUG COMBINATIONS; ETHINYL ESTRADIOL; FEMALE; HUMANS; LINEAR MODELS; MALE; PATIENT SATISFACTION; PROSPECTIVE STUDIES; QUESTIONNAIRES; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUAL PARTNERS; TIME FACTORS; UNITED STATES; YOUNG ADULT;

EID: 72749086118     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.09.066     Document Type: Article

References (23)

1. Laumann E.O., Paik A., and Rosen R.C. Sexual dysfunction in the United States: prevalence and predictors. JAMA 281 (1999) 537-544
2. Mosher W.D., Martinez G.M., Chandra A., Abma J.C., and Willson S.J. Use of contraception and use of family planning services in the United States: 1982-2002. Adv Data 350 (2004) 1-36
3. Bancroft J., Sherwin B.B., Alexander G.M., Davidson D.W., and Walker A. Oral contraceptives, androgens, and the sexuality of young women: II. The role of androgens. Arch Sex Behav 20 (1991) 121-135
4. Greco T., Graham C.A., Bancroft J., Tanner A., and Doll H.A. The effects of oral contraceptives on androgen levels and their relevance to premenstrual mood and sexual interest: a comparison of two triphasic formulations containing norgestimate and either 35 or 25 microg of ethinyl estradiol. Contraception 76 (2007) 8-17
5. Guichoux J.Y. Methodological problems in the evaluation of drug induced sexual dysfunction for oral contraceptives. Therapie 48 (1993) 447-451
6. Graham C.A., and Sherwin B.B. The relationship between mood and sexuality in women using an oral contraceptive as a treatment for premenstrual symptoms. Psychoneuroendocrinology 18 (1993) 273-281
7. Sabatini R., and Cagiano R. Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives. Contraception 74 (2006) 220-223
8. Caruso S., Agnello C., Intelisano G., Farina M., Di Mari L., Sparacino L., et al. Prospective study on sexual behavior of women using 30 microg ethinylestradiol and 3 mg drospirenone oral contraceptive. Contraception 72 (2005) 19-23
9. Guida M., Di Spiezio Sardo A., Bramante S., Sparice S., Acunzo G., Tommaselli G.A., et al. Effects of two types of hormonal contraception-oral versus intravaginal-on the sexual life of women and their partners. Hum Reprod 20 (2005) 1100-1106
10. McCoy N.L., and Matyas J.R. Oral contraceptives and sexuality in university women. Arch Sex Behav 25 (1996) 73-90
11. Bancroft J., Davidson D.W., Warner P., and Tyrer G. Androgens and sexual behaviour in women using oral contraceptives. Clin Endocrinol (Oxf) 12 (1980) 327-340
12. Gracia C.R., Sammel M.D., Freeman E.W., Liu L., Hollander L., and Nelson D.B. Predictors of decreased libido in women during the late reproductive years. Menopause 11 (2004) 144-150
13. Timmer C.J., and Mulders T.M. Pharmacokinetics of etonogestrel and ethinylestradiol released from a combined contraceptive vaginal ring. Clin Pharmacokinet 39 (2000) 233-242
14. Henzl M.R., and Loomba P.K. Transdermal delivery of sex steroids for hormone replacement therapy and contraception. A review of principles and practice. J Reprod Med 48 (2003) 525-540
15. Audet M.C., Moreau M., Koltun W.D., Waldbaum A.S., Shangold G., Fisher A.C., et al. Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial. JAMA 285 (2001) 2347-2354
16. Veres S., Miller L., and Burington B. A comparison between the vaginal ring and oral contraceptives. Obstet Gynecol 104 (2004) 555-563
17. Creinin M.D., Meyn L.A., Borgatta L., Barnhart K., Jensen J., Burke A.E., et al. Multicenter comparison of the contraceptive ring and patch: a randomized controlled trial. Obstet Gynecol 111 2 Pt 1 (2008) 267-277
18. Basson R., Berman J., Burnett A., Derogatis L., Ferguson D., Fourcroy J., et al. Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. J Urol 163 (2000) 888-893
19. Meston C.M. Validation of the Female Sexual Function Index (FSFI) in women with female orgasmic disorder and in women with hypoactive sexual desire disorder. J Sex Marital Ther 29 (2003) 39-46
20. Rosen R., Brown C., Heiman J., Leiblum S., Meston C., Shabsigh R., et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 26 (2000) 191-208
21. Wiegel M., Meston C., and Rosen R. The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther 31 (2005) 1-20
22. Oranratanaphan S., and Taneepanichskul S. A double blind randomized control trial, comparing effect of drospirenone and gestodene to sexual desire and libido. J Med Assoc Thai 89 Suppl 4 (2006) S17-S22
23. Shindel A.W., Ferguson G.G., Nelson C.J., and Brandes S.B. The sexual lives of medical students: a single institution survey. J Sex Med 5 (2008) 796-803